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Abstract
A low-protein high carbohydrate (LPHC) diet and a high-protein low carbo-
hydrate (HPLC) diet have been reported to positively and negatively regulate
whole-body glucose tolerance and insulin sensitivity, respectively. Skeletal
muscle is quantitatively the most important tissue clearing glucose in the post-
prandial state, but it is unclear if LPHC and HPLC diets directly influence
insulin action in skeletal muscle. To test this, mice were placed on control
chow diet, LPHC and HPLC diets for 13.5 weeks at which time the submaxi-
mal insulin-stimulated glucose transport and insulin signaling were evaluated
in ex vivo incubated oxidative soleus and glycolytic EDL muscle. At the
whole-body level, the diets had the anticipated effects, with LPHC diet
improving glucose tolerance and insulin-sensitivity whereas HPLC diet had
the opposite effect. However, neither insulin-stimulated Akt/TBC1D4 signaling
and glucose transport ex vivo, nor cell signaling in vivo were altered by the
diets. These data imply that skeletal muscle insulin sensitivity does not con-
tribute to the whole-body effects of LPHC and HPLC diets on glucose
metabolism.
Introduction
The relative dietary protein content is increasingly recog-
nized to markedly influence whole-body insulin sensitiv-
ity. Thus, lowering the protein content to <~10 energy
(E) % is associated with increased whole-body glucose
tolerance and increased insulin sensitivity measured as
HOMA-IR index in mice and humans (Laeger et al. 2014;
Solon-Biet et al. 2014, 2015; Maida et al. 2016). Con-
versely, diets deriving a high percentage of total energy
from protein, negatively affect whole-body glucose meta-
bolism in mice (Solon-Biet et al. 2014, 2015).
Mechanistically, release of the stress hormone FGF21
from the liver is a hallmark response to LPHC diets and
FGF21 is required for many of the beneficial effects of
low-protein diets, including the effects on whole-body
insulin-sensitivity (Laeger et al. 2014; Fontana et al. 2016;
Maida et al. 2016). The LPHC diet-stimulated rise in
FGF21 has been shown to increase adiponectin, a hor-
mone proposed to mediate the effects of FGF21 on
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insulin sensitivity in different organs, including skeletal
muscle (Lin et al. 2013; Vu et al. 2013; Maida et al. 2016;
Ahlstrom et al. 2017; Li et al. 2018). Adiponectin stimula-
tion has been shown to activate AMPK in skeletal muscle
(Zhou et al. 2009; Yoon et al. 2006; Iwabu et al. 2010), a
protein necessary and sufficient to increase skeletal muscle
insulin sensitivity via a muscle-intrinsic mechanism, that
is, retained in isolated incubated muscles (Kjobsted et al.
2015, 2017). In addition, LPHC diet and the resulting
increases in FGF21 and adiponectin might inhibit several
factors suggested to cause insulin resistance in the diet-
induced obese setting, including ceramides, ectopic lipid
accumulation, and pro-inflammatory skewing of macro-
phages (Holland et al. 2013; Laeger et al. 2014, 2016;
Maida et al. 2016; Li et al. 2018). Decreasing these factors
might also influence insulin action in the isolated muscle.
In relation to increased protein intake, branched chain
amino acids (BCAAs) have repeatedly been associated with
insulin resistance in rodents and humans (Newgard et al.
2009; Solon-Biet et al. 2014). Importantly, specific lowering
of BCAAs in an otherwise isocaloric and isonitrous diet, or
a high fat-high sugar western diet, improved insulin resis-
tance in obese insulin-resistant rodent models (White et al.
2016; Cummings et al. 2018). BCAAs were proposed to
cause rodent skeletal muscle insulin resistance by several
mechanisms: (1) activation of mTORC1 in skeletal muscle
to impair insulin signaling at the level of IRS1 (Newgard
et al. 2009; Lynch and Adams 2014). (2) increased substrate
load on mitochondria to impair lipid oxidation and pro-
mote accumulation of incompletely oxidized fatty acids
(Koves et al. 2008; Lerin et al. 2016; White et al. 2016) and
(3) stimulation of transendothelial fatty acid transport to
promote skeletal muscle lipotoxicity (Jang et al. 2016). The
latter in particular might negatively influence skeletal mus-
cle insulin action in a muscle-intrinsic manner ex vivo sim-
ilar to diet-induced obese models (Frosig et al. 2013; Sylow
et al. 2014).
Skeletal muscle is quantitatively the largest contributor
to whole-body glucose disposal during insulin-stimulated
conditions (DeFronzo et al. 1981), and reduced skeletal
muscle insulin action is also an early contributor and
determinant of systemic glucose intolerance in the patho-
physiology of type 2 diabetes (DeFronzo and Tripathy
2009). Therefore, we undertook the current study to
directly test if the whole-body effects of a 5E% protein
LPHC or a 40E% HPLC diet provided for 13.5 weeks
would elicit muscle-intrinsic changes in insulin-sensitivity.
However, despite confirming the previously reported ben-
eficial and detrimental effects of LPHC and HPLC diets
on whole-body glucose metabolism, respectively, insulin
action in isolated incubated skeletal muscle was unaf-
fected. This suggests that the effects of low/high protein
diets on glucose metabolism and insulin sensitivity are




Chow, LPHC and HPLC diets were purchased from Spe-
ciality Feeds (Australia) and are described in Table 1. Fol-
lowing acclimation for 1 week, 8–9 months old C57BL/
6JRj female retired breeder mice (Janvier Labs, France)
were randomized to Chow (n = 7, one mouse died during
the experiment), LPHC (n = 8) or HPLC (n = 8) groups
and were group-housed at 22–24°C on a 12-h light/12-h
dark-cycle with ad libitum access to water and diets for
13.5 weeks (Table 1 and Fig. 1). Retired female breeders
were chosen to validate the diet effects in middle-aged mice
for a separate follow-up study and because the thin muscles
from female mice are in theory less prone to hypoxia dur-
ing ex vivo incubation (Bonen et al. 1994). Magnetic reso-
nance imaging was performed at week (W) 0 and W13 to
determine body composition. Food intake was measured
weekly from W2 to W11. In W11, the mice were single-
housed on their respective diets for 3 days before perform-
ing indirect calorimetry and activity measurements for
24 h. 1 day before the end of W13, a modified glucose tol-
erance test (GTT) was performed. The mice were then
allowed to recover for 4 days before the terminal experi-
ment with harvest of tissues and ex vivo muscle incubation.
The individual procedures and analyses are detailed below.
Body composition (BC) determination
After weighing, BC of individual conscious fed mice was
determined in an EchoMRITM 4-in-1-500 Body Composi-
tion Analyzer between 9 and 12 AM according to the man-
ufacturer0s instructions.
Indirect calorimetry and habitual activity
Three days before the measurement, mice were acclimated
to single housing in metabolic cages (PhenoMaster, TSE,
Germany) with free access to food and water gel. After
acclimation, habitual activity, measured as laser beam
break counts, expired carbon dioxide (CO2), and oxygen
(O2) consumption were monitored over the next 2 days.
The data from the last 24 h were used in the analysis.
Energy intake
Food intake was measured three times per week between
9 and 11 AM. In brief, the weight of the food pellets was
measured before and after placement on the cage. The
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food intake was converted into energy intake by multiply-
ing with the net metabolizable energy and then divided
by the total number of mice in a given cage.
Modified glucose tolerance test (GTT) and
plasma collection
On the experimental day, the mice were weighed, single-
housed in clean cages and deprived of food from 7 to
8 AM for 6 h. A glucose solution (1 g/5 mL) was prepared
by dissolving glucose in saline 1 h before the GTT. Blood
glucose was monitored, using a standard glucometer
(Contour XT, Bayer’s). For plasma isolation and insulin
measurements, ~50 lL of blood was collected pre and at
30 min postintraperitoneal injection of the glucose solu-
tion (10 lL/g body weight). After the last blood samples
were drawn, the mice were immediately allowed access to
their respective diets again.
Tissue harvest and muscle incubation
Mice were fasted for 2–3 h from 9 AM. Extensor digito-
rum longus (EDL) and soleus (SOL) muscles were care-
fully dissected from mice anesthetized with pentobarbital
Figure 1. Schematic overview of the experimental design. BC,
body composition. FI, food intake; MC, metabolic cage; G, glucose
tolerance test; MI, muscle incubation and tissue harvest; W, week.
Table 1. Dietary composition.
Chow LPHC HPLC
Net metabolizable energy (MJ/Kg) 14.4 15.6 15.5
Total calculated netmetabolizable energy from (%) Lipid 17.8 20.7 30.5
Protein 18.8 4.8 40.6
Carbohydrate 63.4 74.5 28.9
Calculated amino acids (%) Valine 1.26 0.36 3.05
Leucine 1.8 0.5 4.2
Isoleucine 0.87 0.29 2.45
Threonine 0.79 0.21 1.8
Methionine 0.84 0.23 1.93
Cysteine 0.05 0.04 0.36
Lysine 1.49 0.38 3.19
Phenylalanine 0.99 0.27 2.31
Tyrosine 1.04 0.31 2.59
Tryptophan 0.27 0.07 0.6
Histidine 0.6 0.16 1.39
Ingredient (g/kg) Casein 200 55 462
Sucrose 100 66 67
Soy oil 70 88 129
Cellulose 50 0 52
Wheat starch 404 650 143
Dextrinised starch 132 99 100
DL methionine 3 0.8 6.9
Calcium carbonate 13.1 13.1 13.1
Sodium Chloride 2.6 2.6 2.6
AIN93 trace minerals 1.4 1.4 1.4
Potassium dihydrogen phosphate 6.9 6.9 6.9
Potassium sulfate 1.6 1.6 1.6
Potassium citrate 2.5 2.5 2.5
Choline Chloride (75%) 2.5 2.5 2.5
AIN93 vitamins 10 10 10
Physical property Pellet diameter (mm) 12 12 12
Color White White White
Cereal/semi. pure Semi. pure Semi. pure Semi. pure
Reference number SF14-162 SF09-048 SF09-069
LPHC, low protein high carbohydrate diet; HPLC, high protein low carbohydrate diet.
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6 mg and 0.2 mg lidocaine/100 g body weight. The
excised muscles were pinned vertically at approximately
resting length onto a custom-made silicon-base on plastic
holders and placed in glass tubes containing Krebs–
Ringer–Henseleit (KRH) buffer supplemented with
2 mmol/L pyruvate and 8 mmol/L mannitol in glass
tubes with continuous bubbling with 95% O2 and 5%
CO2 at 30°C. After 30 min, the plastic holders with mus-
cles were transferred to new tubes containing
KRH  1.8 nmol/L insulin to elicit a submaximal stimu-
lation of insulin signaling and glucose transport (Frosig
et al. 2013). After 10 min insulin stimulation, the plastic
holders were transferred to new tubes containing
KRH  1.8 nmol/L insulin in tracer medium (1 mmol/L
2-deoxy glucose (2DG), 2-[2,6-3H] deoxy-D-glucose and
[1-14C] mannitol (Amersham Biosciences; specific activi-
ties of the two tracers in the medium were 0.13 and
0.11 lCi mL1, respectively) for 10 min. Finally, the
muscles were quickly rinsed in ice-cold KRH, blot-dried
on paper tissue and snap frozen in liquid N2.
Tibialis anterior (TA) muscles were collected and snap
frozen in liquid N2 before excision of EDL muscles. After
EDL and SOL were dissected out, a piece of the most ven-
tral lobe of the liver was collected and snap frozen in liquid
N2. Blood was then collected from the punctured heart and
thoracic cavity and centrifuged to obtain plasma.
Plasma FGF21, insulin measurements and
HOMA2-IR
Plasma FGF21 and insulin concentration were measured,
using ELISA kits from BioVendor (Cat. RD291108200R)
and ALPCO (Cat. 80-INSMSU-E10), respectively. The
measurements were performed strictly according to the
manufacturers’ instructions. HOMA2-IR, a validated esti-
mate of insulin resistance in mice (Mather 2009), was cal-
culated using the fasting glucose and insulin values.
Liver and muscle glycogen content
However, 10–30 mg of frozen liver tissue or TA muscle
and 200 lL of 1 N HCL were added to 1.5 mL tubes and
boiled on a heating block at 98°C for 2 h. Glycogen con-
tent was then measured as glycosyl units after acid
hydrolysis and glucose was determined fluorometrically
from the neutralized perchloric acid extracts (Lowry and
Passonneau 1972).
Protein extraction
Here, 15 mg of liver or TA muscle, or the entire EDL
and SOL muscles, trimmed free of visible fat and tendons,
and weighed, were added to ice-cold 2 mL centrifuge
tubes containing a steel bead and 300 lL lysis buffer
(0.05 mol/L Tris Base pH 7.4, 0.15 mol/L NaCl, 1 mmol/
L EDTA and EGTA, 0.05 mol/L sodium flouride,
5 mmol/L sodium pyrophosphate, 2 mmol/L sodium
orthovanadate, 1 mmol/L benzamidine, 0.5% protease
inhibitor cocktail (P8340, Sigma Aldrich), and 1% NP-
40) and lysed for 1 min at 30 Hz on a shaking bead-mill
(TissueLyser II, Qiagen, Valencia, CA, USA). The samples
were then rotated end-over-end at 4°C for 30 min fol-
lowed by centrifugation at 18.320g at 4°C for 20 min to
recover supernatants (lysates) for western blotting and
2DG transport determination.
Lysate preparation for Western blotting
The protein content of liver or muscle lysate was deter-
mined, using the BCA method (ThermoFisher, Cat.
23235). Thereafter, equivalent amounts of protein were
mixed with 69 Laemmli sample buffer (11% SDS,
225 mmol/L Dithiothreitol (DTT), 340 mmol/L Tris, pH
6.8, 0.05% bromophenol blue, 20% glycerol) and appro-
priate amounts of deionized water and boiled at 95°C for
5 min.
Western blotting
Equivalent amounts of protein from liver, TA, EDL or
SOL were subjected to 5–15% SDS-PAGE and semi-dry
transferred to PVDF membranes. After that, the mem-
branes were blocked in 3–5% BSA or skim milk, depend-
ing on the primary antibody to be used at room
temperature for 1 h followed by overnight incubation
with primary antibody. The next day, the membranes
were washed with TBS-T and incubated with the relevant
horseradish peroxidase-conjugated secondary antibodies
for 1 h and washed with TBS-T again. The amount of
bound antibody was measured using enhanced chemilu-
minescence (ECL+; Amersham Biosciences, Little Chal-
font, UK) and images for densitometry were captured,
using a ChemiDoc MP Imaging System (Bio-Rad, Her-
ules, CA, USA). After development, the membranes were
stained with Coomassie Brilliant Blue to verify even trans-
fer and similar total protein loading.
For the cell culture positive control lysates, confluent
6-well dishes with fed HEK293 cells were lysed in 100 lL
of lysis buffer, and HeLa cells lysates stimulated with
100 nmol/L calyculin A for 30 min was a gift from
Abcam. Both lysates were then further processed as
above.
The primary antibodies used were phospho-eIF2a
Ser51 (Cell Signaling Technology (CST), 9721), phospho-
GCN2 Thr899 (Abcam, ab75836), phospho-Erk1/2
Thr202/Tyr204 (CST, 4370), phospho-p38 MAPK
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Thr180/Tyr182 (CST, 9211), phospho-AMPK Thr172
(CST, 50081), phospho-Akt Thr308 (CST, 13038), phos-
pho-Akt S473 (CST, 4060), phospho-4E-BP1 Ser65 (CST,
9451), phospho-S6 Ser235/236 (CST, 4858), phospho-
p70S6K Thr389 (CST, 9206), phospho-TBC1D4 Thr642
(CST, 8881), phospho-TBC1D1 S237 (Millipore, 07-
2268), phospho-ACC S212 (Millipore, 03 303), Perilipin2
(Novus Biologicals, NB110-40877), Akt2 (CST, 2964) and
p70S6K (CST, 9202), Hexokinase II (HKII) (CST, 2867),
GLUT4 (ThermoFisher Scientific, PA-23052).
2-Deoxy-D-glucose (2DG) transport
For analysis of 2DG transport, 100 of 300 lL total muscle
lysate were mixed with 2 mL of Ultima GoldTM scintilla-
tion cocktail (Perkin Elmer, MA, USA). Then the samples
were vigorously shaken for 3 min and radioactivity was
measured using liquid scintillation counting (Tri-Carb
2000; Packard Instrument, Downers Grove, IL).
Statistical analyses of data
Results are expressed as means  SEM. Statistical tests
were performed using 2-way ANOVA or repeated mea-
surements ANOVA followed by Tukey0s post hoc test
where appropriate using SPSS 22 and GraphPad Prism 7.
In cases where the data could not pass Levene’s equal
variance test even after transformation, a nonparametric
test was applied as indicated in the figure legend. The sig-
nificance level was set at P < 0.05. Number written above
bars in figures highlights a tendency to significant P value
of P < 0.1.
Results
To test the effects of dietary protein content on skeletal
muscle insulin sensitivity, 8–9 months old middle-aged
female C57BL/6 mice were placed in groups of 7–8 mice
on either chow diet deriving 64/19/18E% from carbohy-
drate/protein/fat, LPHC diet deriving 75/5/21E% from
carbohydrate/protein/fat or HPLC diet deriving 29/41/
31E% from carbohydrate/protein/fats (Table 1). These
diets were selected based on their efficacy in a previous
study (Solon-Biet et al. 2014). As expected, mice on the
LPHC diet consumed more energy on average than
chow-fed mice (Fig. 2A). There were no changes in body
or fat mass on these diets, but mice on the LPHC diet
had a slight decrease in lean body mass in W13 compared
to the other groups (Fig. 2B). In the respiratory chamber,
measurements performed in W11 of the diet-study, respi-
ratory exchange ratio (RER) was lower in mice on HPLC
diet (Fig. 2C), habitual activity was not different
(Fig. 2D) and the O2 consumption was stimulated by the
LPHC diet (Fig. 2E). Collectively, these data are well in
line with previous data showing that LPHC diet induces
hyperphagia and O2 consumption independent of habit-
ual activity, likely by stimulating adaptive thermogenesis
in brown and white adipose tissues.
Liver plays a key role in the adaptive response to LPHC
diet by releasing the stress hormone FGF21, which is reg-
ulated by both protein and carbohydrate content of the
diet (Solon-Biet et al. 2016). As expected, the carbohy-
drate content of the diets was reflected in the liver glyco-
gen (Fig. 3A). Also, the LPHC diet dramatically increased
plasma FGF21 compared to chow (Fig. 3B), while the
HPLC diet group showed a tendency (P = 0.09) toward
lower FGF21. FGF21 release from liver is described to
involve a GCN2/eIF2a-dependent signaling pathway. Pre-
sently, the LPHC but not the HPLC diet increased eIF2a
Ser51phosphorylation but not GCN2 Thr899 autophos-
phorylation (Fig. 3C). In contrast, mTORC1 substrate
phosphorylation was surprisingly increased much more
potently by the LPHC diet than by the HPLC diet
(Fig. 3C), differing markedly from earlier reports (Solon-
Biet et al. 2014; Maida et al. 2017). However, we did not
further investigate the reason for this discrepancy since
this was not the aim of the study. No other measured
phosphorylations or proteins responded significantly to
the diets, including phosphorylation of ERK, p38 MAPK,
AMPK, Akt, and expression of Perilipin 2 and Akt2
(Fig. 3C).
To evaluate the impact of diet on whole-body insulin
sensitivity, a modified glucose tolerance test was per-
formed. Blood glucose and plasma insulin were measured
before and 30 min after injection of a standardized glu-
cose load. In this setup, glucose tolerance was augmented
by the LPHC diet and impaired by the HPLC diet com-
pared to chow (Fig. 4A). This was associated with a
change in whole-body insulin sensitivity since both the
fasting and glucose-stimulated insulin concentration was
lower in the LPHC group compared to the two other
groups, whereas the insulin levels on the HPLC diet were
comparable to chow (Fig. 4B). Thus, our diets recapitu-
late previous findings of increased and decreased whole-
body glucose tolerance and insulin sensitivity in the con-
text of LPHC and HPLC diet, respectively.
After 13.5 weeks on chow, LPHC or HPLC diet, we
performed ex vivo incubations to evaluate possible mus-
cle-intrinsic changes in insulin sensitivity. To achieve
this, we measured cell signaling and glucose transport in
the slow-twitch oxidative soleus muscle and the fast-
twitch glycolytic EDL muscle at rest or during stimula-
tion with a submaximal 1.8 nmol/L insulin, that is, an
insulin concentration in which detection of either
increased or decreased insulin sensitivity should be pos-
sible. In both muscles, insulin had significant
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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stimulatory effects on Akt and TBC1D4 phosphorylation
(Fig. 4C and E) and glucose transport (Fig. 4D and F).
However, there were no discernible effects of diet on
these parameters.
An FGF21-adiponectin axis has been proposed to mediate
the benefits of low-protein diet. This would be predicted to
activate AMPK in skeletal muscle. Also, our findings in liver
of increased glycogen and mTORC1 signaling on LPHC diet
prompted us to investigate the same in skeletal muscle, in
particular given that the tight correlation between glycogen,
AMPK and insulin sensitivity (Wojtaszewski et al. 2002).
We therefore also measured glycogen and a number of phos-
phorylations in TA muscle snap-frozen immediately after
excision. No significant changes were observed in neither
glycogen (Fig. 5A) nor cellular signaling (Fig. 5B). Taken
together, this suggests that the effects of chronic LPHC and
HPLC diets on whole-body insulin sensitivity are not medi-
ated via skeletal muscle.
Figure 2. Chronic low protein high carbohydrate diet (LPHC) increased metabolic rate. (A) Average energy intake calculated as whole cage
energy consumption/number of mice in a given cage. The color legend in panel A is shared with panel B–E. (B) Fat mass, lean mass and body
mass measured pre- and post-12 weeks of dietary intervention. #P < 0.05 main effect of dietary intervention. **P < 0.01 versus chow/P < 0.05
versus LPHC within lean post. (C–E) Respiratory exchange ratio (RER), habitual activity and oxygen consumption, respectively, in week 12 of the
dietary intervention were recorded for 24 h, from which the average RER, habitual activity and oxygen consumption within light and dark-
phase were calculated (C, D & E right). For (C), interaction effect (P = 0.027); ***P < 0.001 versus chow/P < 0.001 versus LPHC within dark;
P < 0.05 versus LPHC within the light phase. For (D), $$$P < 0.001 main effect of light phase. For (E), */**P < 0.05/0.01 versus chow within
dark phase; Kruskal–Wallis test, a nonparametric test, followed by Dunn’s multiple comparison test was applied to evaluate significance within
light phase. Data are expressed as mean  SEM. N = 7 for chow and n = 8 for LPHC/HPLC.
2018 | Vol. 6 | Iss. 13 | e13798
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Discussion
Whole-body insulin sensitivity is inversely associated with
the protein content of the diet but the contribution of
skeletal muscle, the body0s largest insulin-stimulated glu-
cose storage site to this association, has not been directly
investigated. Presently, we demonstrate that insulin-sensi-
tivity in isolated skeletal muscle is indistinguishable
between diets despite marked changes in whole-body
insulin sensitivity and that cell signaling in skeletal muscle
in vivo is not affected despite marked changes in whole-
body insulin sensitivity. This implies that the inverse asso-
ciation between protein content and insulin sensitivity is
not mediated via changes in skeletal muscle insulin
action.
We presently evaluated insulin action in incubated
rodent skeletal muscle, a classical experimental setup to
study glucose metabolism (Bonen et al. 1994). The iso-
lated muscle setup relies on simple diffusion of substrates
rather than the vasculature, and is limited by glucose
transport across the surface membrane rather than intra-
cellular phosphorylation by hexokinase II (Hansen et al.
2000). Therefore, this model isolates the glucose transport
step, believed to depend mainly on GLUT4 translocation
(Zisman et al. 2000) although this is not entirely clear
(Fam et al. 2012). The clear advantage of the incubation
model is that it is void of systemic influence and that any
phenotype must be a direct and intrinsic feature of skele-
tal muscle. This model has previously been used to study
both insulin sensitizing (Kjobsted et al. 2017) and insu-
lin-resistance-promoting conditions (Frosig et al. 2013).
However, a limitation of the model is that it does not
accurately reflect the in vivo conditions where delivery of
glucose and insulin via the vasculature, transport and
intracellular metabolism may all regulate the overall rate
of skeletal muscle glucose uptake. Therefore, our data,
strictly speaking, only rule out an effect of diet on insulin
signaling and glucose transport in skeletal muscle. Other
sites of regulation might contribute to altered insulin-sti-
mulated glucose uptake in muscle including muscle blood
flow (Sjoberg et al. 2017) and intracellular metabolism
(Fueger et al. 2003, 2004). Both adiponectin and BCAA
might influence muscle flow via effects on the vasculature
(de Boer et al. 2016; Jang et al. 2016). Future studies
should ascertain whether low and high-protein diets
might influence skeletal muscle insulin-stimulated glucose
uptake in vivo using, for example, hyperinsulinemic eug-
lycemic clamp studies.
If not skeletal muscle, then what drives the improved
glucose metabolism on a LPHC diet? FGF21 appears to be
required for the metabolic effects of an LPHC diet (Laeger
et al. 2014; Maida et al. 2016). The metabolic improve-
ments in glucose and insulin tolerance induced by recombi-
nant FGF21 required the expression of the FGF21
co-receptor b-Klotho in white adipose tissue (BonDurant
et al. 2017; Li et al. 2018), suggesting a dependence on
FGF21-action in white adipose tissue. Li et al. 2018 sug-
gested that FGF21 promoted healthy expansion of subcuta-
neous white adipose tissue, increased adiponectin release
and anti-inflammatory M2 macrophage polarization. Adi-
ponectin in turn might influence insulin sensitivity in tar-
get organs such as liver and skeletal muscle (Yamauchi
Figure 3. Chronic low protein high carbohydrate diet (LPHC)
increased plasma FGF21 and altered liver cellular signaling. (A) Liver
glycogen content. The color legend in panel A is shared with panel
B–C. P < 0.01 versus LPHC. (B) Plasma FGF21. ***P < 0.001 versus
chow/P < 0.001 versus LPHC. (C) Liver cellular signaling determined
by western blotting. The signal intensities are presented relative to
chow (dashed line). Representative blots and a coomassie loading
control are shown to the left. Kruskal–Wallis test, a nonparametric
test, followed by Dunn’s multiple comparison test was applied to
evaluate significance within S6 S235/236. HPLC, high protein low
carbohydrate diet. */**/***P < 0.05/0.01/0.001 versus chow/
P < 0.05/0.001 versus LPHC. Data are expressed as mean  SEM.
N = 7 for chow and n = 8 for LPHC/HPLC.
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et al. 2002; Yano et al. 2008; Vu et al. 2013; Ahlstrom et al.
2017). However, the requirement for adiponectin in medi-
ating the metabolic effects of FGF21 is currently disputed
with studies showing either a strong dependency of FGF21
metabolic actions on adiponectin (Holland et al. 2013; Lin
et al. 2013) or none (BonDurant et al. 2017). Consistent
with a largely adiponectin-independent mode of action for
FGF21, hyperinsulinemic-euglycemic clamp studies in mice
showed that both single-dose and chronic recombinant
FGF21 treatments affected insulin-sensitivity mainly in liver
and adipose tissue but not muscle (Xu et al. 2009a,b). The
glycemic improvements by FGF21 in mice are seemingly
independent of liver insulin-sensitization (Emanuelli et al.
2014) but requires functional FGF21 signaling in brown
Figure 4. Alterations in whole body glucose tolerance by low protein high carbohydrate diet (LPHC) and high protein low carbohydrate diet
(HPLC) are not reflected in isolated skeletal muscles. (A) A 30 min intra-peritoneal glucose challenge (GTT) was performed one day before the
end of week 13, during which blood samples were drawn before and at 300 to measure the corresponding plasma insulin and to calculate
HOMA2-IR in panel B and C, respectively). The color legend in panel C is shared with panel A–G. For (A), interaction effect (P < 0.001);
*/**P < 0.05/0.01 versus chow/P < 0.01 versus LPHC within 300. For (B), Kruskal–Wallis test, a nonparametric test, followed by Dunn’s multiple
comparison test was applied to evaluate significance within 300; *P < 0.05 versus chow within 00; **P < 0.01 versus chow/P < 0.05 versus
LPHC within 300. For (C), *P < 0.05 versus chow. For (D–G), Submaximal insulin-stimulated muscle signaling and corresponding ex vivo 2-
Deoxy-D-glucose (2DG) transport measured in D & E) for Extensor digitorum longus (EDL), and in F &G) for soleus (SOL) muscles. For D–G,
#P < 0.05 main effect of dietary intervention; $/$$$P < 0.05/0.001 main effect of insulin. (H) Representative blots and coomassie loading
control for E & F. C, chow; L, LPHC; H, HPLC. Ins, insulin. Data are expressed as mean  SEM. N = 7 for chow and n = 8 for LPHC/HPLC in A,
B, E and F. One EDL was lost during processing, therefore, the basal HPLC groups in C + D were n = 7.
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adipose tissue (BonDurant et al. 2017) independent of the
major intrascapular brown adipose tissue depot (Emanuelli
et al. 2014; Bernardo et al. 2015). Our current data of unal-
tered in vivo AMPK signaling in skeletal muscle favor that
insulin-sensitization by the LPHC diet is skeletal muscle
independent despite the reported increase in adiponectin
by the LPHC diet in many studies. Although care should be
taken when inferring from the typically higher blood con-
centration of FGF21 reached in injection studies versus
LPHC diet studies, we speculate that the LPHC diet
increases brown adipose tissue glucose uptake to improve
glycemia similar to what is observed with recombinant
FGF21 administration.
Our liver signaling data showed elevated phosphoryla-
tion of mTORC1 substrate p70S6K Thr389 on a HPLC diet.
However, it is unlikely that mTORC1 hyperactivation sup-
pressed insulin action (Um et al. 2004) in this dietary set-
ting, since a much higher liver phosphorylation of p70S6K
in the LPHC diet setting coincided with increased whole-
body insulin sensitivity. No difference in p70S6K signaling
was observed in skeletal muscle in response to either diet. It
should be noted that although skeletal muscle is believed to
play a prominent role in BCAA-induced insulin resistance,
other organs such as adipose tissue and liver might directly
or indirectly contribute to BCAA-metabolism or BCAA-
induced insulin resistance (Herman et al. 2010; Ananieva
et al. 2017). Furthermore, not all studies report detrimental
effects of elevated BCAA on health parameters (She et al.
2007; D’Antona et al. 2010; Macotela et al. 2011), perhaps
because BCAA metabolites rather than BCAAs per se are
the driver of insulin resistance. Regardless of the mecha-
nism, our data suggest that skeletal muscle insulin resis-
tance is either not involved in the detrimental effect of
HPLC diet on whole-body insulin sensitivity in normal
healthy muscle or that the effect is rapidly washed out
ex vivo. The latter seems unlikely if the HPLC diet works
mechanistically by promoting lipotoxicity in muscle since
high-fat diet induced insulin resistance in muscle is
retained ex vivo (Frosig et al. 2013). However, further stud-
ies are needed to clarify this.
In summary, we presently tested whether the changes
in insulin sensitivity, induced by a 40 E% high or a 5 E%
low-protein diet, at the whole-body level correlated with
changes in skeletal muscle insulin signaling and glucose
transport and found no evidence that skeletal muscle is
involved. This suggests that other organs than skeletal
muscle are the drivers of the whole-body changes in insu-
lin sensitivity in these dietary settings.
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